| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 46.8K | $1.8M | $38.49 | Apr 25, 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
| Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25K | May 30, 2024 | Direct | ||
| Syneos Health, Inc. | Director | Class A Common Stock | 0 | $43.00 | Sep 28, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | May 30, 2024 | 1 | $0 | 4 | Jun 3, 2024 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
| SYNH | Syneos Health, Inc. | Sep 28, 2023 | 2 | -$426K | 4 | Sep 28, 2023 | Director |
| EDIT | Editas Medicine, Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director |
| SYNH | Syneos Health, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2023 | 2 | $0 | 4 | May 9, 2023 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | Nov 16, 2022 | 1 | $0 | 4 | Nov 17, 2022 | Director |
| EDIT | Editas Medicine, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| SYNH | Syneos Health, Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
| EDIT | Editas Medicine, Inc. | Oct 26, 2021 | 1 | $0 | 4 | Oct 28, 2021 | Director |
| EDIT | Editas Medicine, Inc. | Oct 26, 2021 | 0 | $0 | 3 | Oct 28, 2021 | Director |
| SYNH | Syneos Health, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |